Evidence map›Paper›PMID 39361308›Full record

ArticleClinical and experimental immunology2026

Investigating concomitant RAG-2 and LRBA mutations in SCID and autoimmunity.

Ilia Spivak, Shirly Frizinsky, Amarilla Mandola, Atar Lev, Amos J Simon, Ortal Barel, Vicktoria Vishnevskia-Dai, Raz Somech, Ido Somekh

Abstract readCase Reports
In one paragraph

Article in Clinical and experimental immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ilia SpivakClinical Immunology, Angioedema and Allergy Institute, The Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.ORCID 0000-0001-5950-7437
Shirly FrizinskyFaculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Amarilla MandolaFaculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Atar LevCancer Research Center, Pediatric Immunology Unit, Jeffrey Modell Foundation (JMF) Center, Department of Pediatrics, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel.
Amos J SimonCancer Research Center, Pediatric Immunology Unit, Jeffrey Modell Foundation (JMF) Center, Department of Pediatrics, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel.
Ortal BarelThe Genomic Unit, Sheba Cancer Research Center, Sheba Medical Center, Tel Hashomer, Israel.
Vicktoria Vishnevskia-DaiFaculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Raz SomechFaculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Ido SomekhFaculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Funding

Israeli Science FoundationKronitz Family Sheba Research-Scientist ProgramPersonal Research Grant 3115/19
6 · The paper itself

Abstract

Inborn errors of immunity (IEI) are a large heterogeneous group of diseases characterized by immunodeficiency, immune dysregulation, allergy, auto-inflammation, and predisposition to malignancies. Most are inherited as an autosomal recessive trait. We studied a patient with severe combined immunodeficiency (SCID) and immune dysregulation who harbored two distinct biallelic IEI-associated genetic mutations. Clinical, immunological, and genetic data were collected. Genetic investigation included whole-exome sequencing on DNA extracted from skin fibroblasts. Family segregation was performed by Sanger sequencing. Immunological evaluation included absolute and functional evaluations of lymphocytes and chimerism analysis post-hematopoietic stem cell transplantation (HSCT). Treg subsets, lipopolysaccharide-responsive and beige-like anchor (LRBA), and Cytotoxic T-Lymphocyte Associated protein 4 (CTLA4) expression levels were measured by flow cytometric analysis. A 19-year-old female patient from a consanguineous background underwent unconditioned matched sibling-related HSCT during infancy due to the clinical presentation of SCID with an Omenn phenotype. At that time, her underlying genetic defect was not defined. Years after HSCT, severe autoimmune phenomena were noted, including a systemic lupus erythematosus-like syndrome and ophthalmic manifestations. Genetic evaluation revealed biallelic homozygous mutations in recombination activating gene-2 (c.685C>T, p.Arg229Trp) and a previously undescribed mutation in LRBA (c.3325G>T, p.Asp1109Tyr). LRBA and CTLA4 expression levels were normal, suggesting that the LRBA variant identified in these kindred is unlikely to be pathogenic. Multiple genetic defects causing complex IEIs may be identified in the same individual in highly consanguineous populations. Functional immunological testing is essential for the evaluation of novel genetic variants.

Indexed as

AutoimmunityDNA-Binding ProteinsMutationNuclear ProteinsSevere Combined ImmunodeficiencyAdaptor Proteins, Signal TransducingCTLA-4 AntigenFemaleHematopoietic Stem Cell TransplantationHumansPedigreeT-Lymphocytes, RegulatoryYoung AdultAdaptor Proteins, Signal TransducingCTLA-4 AntigenCTLA4 protein, humanDNA-Binding ProteinsLRBA protein, humanNuclear ProteinsRAG2 protein, humaninborn errors of immunityLRBAOmenn syndromeRAG-2severe combined immunodeficiency

Identifiers

PMID39361308
PMCPMC13032038

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.